S4327Referred to Committee
A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.
Introduced
2
In Committee3
Passed One Chamber4
Passed Both5
Signed into Law119th
Congress
2026-04-16
Introduced
0
Cosponsors
S
ⓘType
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2026-04-16
Read the full bill text